Avalo Therapeutics Inc logo

Avalo Therapeutics Inc share price today

(AVTX)

Avalo Therapeutics Inc share price is $10.15 & ₹859.60 as on 7 Dec 2024, 2.30 'hrs' IST

$10.15

0.17

(1.7%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Avalo Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Avalo Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Avalo Therapeutics Inc. Get details on the Indian mutual funds that are investing in Avalo Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Avalo Therapeutics Inc's financials.

Avalo Therapeutics Inc share price movements

  • $9.67
    $10.46

    Day's Volatility :7.54%

  • $3.95
    $34.46

    52 Weeks Volatility :88.54%

Avalo Therapeutics Inc Returns

PeriodAvalo Therapeutics IncIndex (Russel 2000)
3 Months
22.45%
0.0%
6 Months
-8.61%
0.0%
1 Year
2.67%
0.0%
3 Years
-99.82%
-21.5%

Avalo Therapeutics Inc Key Statistics

in dollars & INR

Previous Close
$9.98
Open
$9.7
Today's High
$10.459
Today's Low
$9.67
Market Capitalization
$104.6M
Today's Volume
$29.7K
52 Week High
$34.46
52 Week Low
$3.9501
Revenue TTM
$820.0K
EBITDA
$-31.2M
Earnings Per Share (EPS)
$94.8
PE Ratio
0.11
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-42.52%

How to invest in Avalo Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Avalo Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avalo Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Avalo Therapeutics Inc or AVTX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avalo Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avalo Therapeutics Inc shares which would translate to 0.083 fractional shares of Avalo Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Avalo Therapeutics Inc

-23%

Period: Sep 8, 2024 to Dec 7, 2024. Change in 30 Days versus previous period

Search volume for Avalo Therapeutics Inc on INDmoney from India has reduced in the last 30 days as on Dec 8, 2024. -23% less investors are searching Avalo Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Avalo Therapeutics Inc

  • Ikarian Capital, LLC

    9.27%

  • Orbimed Advisors, LLC

    9.24%

  • Deep Track Capital, LP

    9.24%

  • Bvf Inc

    9.24%

  • RA Capital Management, LLC

    9.24%

  • Logos Global Management LP

    5.15%

Analyst Recommendation on Avalo Therapeutics Inc

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Avalo Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Avalo Therapeutics Inc

What analysts predicted

Upside of 244.83%

Current:

$10.15

Target:

$35.00

Insights on Avalo Therapeutics Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 571.0K → 249.0K (in $), with an average decrease of 56.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 98.46M → 23.03M (in $), with an average decrease of 76.6% per quarter
  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 42.1% return, outperforming this stock by 73.5%
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.7% return, outperforming this stock by 139.5%

Avalo Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Avalo Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.

Avalo Therapeutics Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Avalo Therapeutics Inc
-25.02%
-8.61%
2.67%
-99.82%
-99.88%
Regeneron Pharmaceuticals, Inc.
-6.86%
-23.34%
-9.49%
15.35%
108.86%
Biontech Se
10.16%
21.29%
18.26%
-58.19%
324.43%
Alnylam Pharmaceuticals, Inc.
-7.5%
64.08%
47.33%
46.0%
106.67%
Vertex Pharmaceuticals Incorporated
-8.46%
-4.83%
29.09%
120.68%
108.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Avalo Therapeutics Inc
0.11
0.11
NA
0.0
-0.43
-0.31
NA
2.18
Regeneron Pharmaceuticals, Inc.
18.56
18.56
1.12
44.92
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Avalo Therapeutics Inc
Sell
$104.6M
-99.88%
0.11
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$82.9B
108.86%
18.56
33.61%
Biontech Se
Buy
$28.5B
324.43%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
106.67%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$118.4B
108.8%
32.84
-4.51%

About Avalo Therapeutics Inc

cerecor inc. is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human brain. we are a delaware corporation, organized in april 2011 in partnership with various laboratories and research institutes at johns hopkins medical institute ("jhmi"). cerecor is focused on translational medicine – the accelerated transfer of technology from the academic laboratory to early human trials, with the goal of rapid commercialization. we acquire rights to early stage therapeutic technologies ("assets") from universities, finance and manage the development of these assets into drug candidates (to first major milestone or value inflection point) and then either commercialize or outlicense the asset.
Organization
Avalo Therapeutics Inc
Employees
19
CEO
Dr. Garry A. Neil M.D.
Industry
Miscellaneous

Management People of Avalo Therapeutics Inc

NameTitle
Dr. Garry A. Neil M.D.
Chairman of the Board, President & CEO
Dr. Solomon H. Snyder M.D.
Founder and Chairman of Scientific Advisory Board
Dr. Barbara S. Slusher Ph.D.
Founder and Member of Scientific Advisory Board
Mr. Paul C. Varki J.D., M.P.H
Chief Legal Officer
Dr. Lisa Hegg Ph.D.
Senior Vice President of Program Management, Corporate Infrastructure & Clinical Operations
Ms. Colleen Matkowski
Senior Vice President of Global Regulatory Affairs & Quality Assurance
Dr. Dino C. Miano Ph.D.
Senior Vice President of CMC & Technical Operations
Dr. Mittie Doyle FACR, M.D.
Chief Medical Officer

Important FAQs about investing in Avalo Therapeutics Inc from India :

What is Avalo Therapeutics Inc share price today?

Avalo Therapeutics Inc (AVTX) share price today is $10.15.

Can Indians buy Avalo Therapeutics Inc shares?

Yes, Indians can invest in the Avalo Therapeutics Inc (AVTX) from India.

With INDmoney, you can buy Avalo Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Avalo Therapeutics Inc at zero transaction cost.

How can I buy Avalo Therapeutics Inc shares from India?

It is very easy to buy Avalo Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avalo Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Avalo Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Avalo Therapeutics Inc stocks?

To start investing in Avalo Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Avalo Therapeutics Inc

Today’s highest price of Avalo Therapeutics Inc (AVTX) is $10.46.

Today’s lowest price of Avalo Therapeutics Inc (AVTX) is $9.67.

What is today's market capitalisation of Avalo Therapeutics Inc

Today's market capitalisation of Avalo Therapeutics Inc AVTX is 104.6M

What is the 52 Week High and Low Range of Avalo Therapeutics Inc

  • 52 Week High

    $34.46

  • 52 Week Low

    $3.95

How much percentage Avalo Therapeutics Inc is down from its 52 Week High?

Avalo Therapeutics Inc (AVTX) share price is $10.15. It is down by 99% from its 52 Week High price of $34.46.

How much percentage Avalo Therapeutics Inc is up from its 52 Week low?

Avalo Therapeutics Inc (AVTX) share price is $10.15. It is up by 1% from its 52 Week Low price of $3.95.

What are the historical returns of Avalo Therapeutics Inc?

  • 1 Month Returns

    -25.02%

  • 3 Months Returns

    -8.61%

  • 1 Year Returns

    2.67%

  • 5 Years Returns

    -99.88%

Who is the Chief Executive Officer (CEO) of Avalo Therapeutics Inc

Dr. Garry A. Neil M.D. is the current Chief Executive Officer (CEO) of Avalo Therapeutics Inc.